Neuroscience

New drug shows promise against multiple sclerosis

An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number ...

Diseases, Conditions, Syndromes

Pregnancy in women with two types of MS may mitigate MS progression

(Medical Xpress) -- Pregnancy appears to have a positive effect on long-term disability in women with two types of multiple sclerosis, indicating that reproductive hormones may play a protective role in MS progression, neurology ...

Immunology

New immunotherapy targeting blood-clotting protein

Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Medical research

New anti-inflammatory molecule could halt MS progression

Walter and Eliza Hall Institute scientists have developed a new drug-like molecule that can halt inflammation and has shown promise in preventing the progression of multiple sclerosis (MS).

Immunology

Researchers discover neuroprotective role of immune cell

A type of immune cell widely believed to exacerbate chronic adult brain diseases, such as Alzheimer's disease and multiple sclerosis (MS), can actually protect the brain from traumatic brain injury (TBI) and may slow the ...

Medical research

New drug to tackle fat problems

Medical researchers at the University of Sheffield have defined the structure of a key part of the human obesity receptor- an essential factor in the regulation of body fat- which could help provide new treatments for the ...

page 17 from 40